BioAffinity Gross Profit from 2010 to 2025

BIAFW Stock

USD 0.60 0.01 1.64%

BioAffinity Technologies Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit bioAffinity Technologies Warrant makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

910.4 K

Current Value

955.9 K

Quarterly Volatility

371.9 K

Credit Downgrade

Yuan Drop

Covid

Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 301.4 K, Interest Expense of 40.6 K or Gross Profit of 955.9 K, as well as many indicators such as Price To Sales Ratio of 5.55, Dividend Yield of 0.0 or PTB Ratio of 2.5. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.

Check out the analysis of BioAffinity Technologies Correlation against competitors.

Latest BioAffinity Technologies' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of bioAffinity Technologies Warrant over the last few years. Gross profit is a required income statement account that reflects total revenue of bioAffinity Technologies Warrant minus its cost of goods sold. It is profit before BioAffinity Technologies operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. BioAffinity Technologies' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.6 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

BioAffinity Gross Profit Regression Statistics

	Arithmetic Mean	139,522
	Geometric Mean	52,752
	Coefficient Of Variation	266.54
	Mean Deviation	279,910
	Median	(40,278)
	Standard Deviation	371,878
	Sample Variance	138.3B
	Range	996.2K
	R-Value	0.70
	Mean Square Error	75.5B
	R-Squared	0.49
	Significance	0
	Slope	54,693
	Total Sum of Squares	2.1T

BioAffinity Gross Profit History

	2025	955.9 K
	2024	910.4 K
	2023	791.6 K
	2022	4336.0
	2021	-4817.0
	2020	-22.2 K

Other Fundumenentals of BioAffinity Technologies

Gross Profit Margin

BioAffinity Technologies Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Intangible Assets
Total Assets		0.8	-0.83	-0.86	0.77	0.62	-0.4	0.93	-0.64	0.95	0.85	0.97	-0.93	0.95	0.97	-0.36	-0.36
Total Stockholder Equity	0.8		-0.95	-0.58	0.62	0.59	-0.85	0.76	-0.96	0.76	0.48	0.83	-0.84	0.77	0.84	-0.45	-0.45
Net Debt	-0.83	-0.95		0.53	-0.48	-0.38	0.77	-0.88	0.86	-0.71	-0.48	-0.84	0.78	-0.71	-0.87	0.27	0.27
Retained Earnings	-0.86	-0.58	0.53		-0.95	-0.84	0.1	-0.71	0.43	-0.88	-0.91	-0.89	0.92	-0.9	-0.86	0.6	0.6
Accounts Payable	0.77	0.62	-0.48	-0.95		0.96	-0.21	0.57	-0.52	0.86	0.81	0.83	-0.92	0.88	0.8	-0.77	-0.77
Net Receivables	0.62	0.59	-0.38	-0.84	0.96		-0.29	0.36	-0.57	0.78	0.66	0.68	-0.83	0.8	0.65	-0.79	-0.79
Total Liab	-0.4	-0.85	0.77	0.1	-0.21	-0.29		-0.38	0.94	-0.39	0.0	-0.41	0.46	-0.39	-0.44	0.23	0.23
Total Current Assets	0.93	0.76	-0.88	-0.71	0.57	0.36	-0.38		-0.55	0.76	0.73	0.93	-0.8	0.76	0.94	-0.26	-0.26
Short Term Debt	-0.64	-0.96	0.86	0.43	-0.52	-0.57	0.94	-0.55		-0.65	-0.29	-0.66	0.73	-0.66	-0.68	0.42	0.42
Common Stock	0.95	0.76	-0.71	-0.88	0.86	0.78	-0.39	0.76	-0.65		0.85	0.9	-0.94	1.0	0.89	-0.42	-0.42
Long Term Debt	0.85	0.48	-0.48	-0.91	0.81	0.66	0.0	0.73	-0.29	0.85		0.81	-0.78	0.85	0.78	-0.39	-0.39
Net Invested Capital	0.97	0.83	-0.84	-0.89	0.83	0.68	-0.41	0.93	-0.66	0.9	0.81		-0.97	0.91	1.0	-0.52	-0.52
Short Long Term Debt	-0.93	-0.84	0.78	0.92	-0.92	-0.83	0.46	-0.8	0.73	-0.94	-0.78	-0.97		-0.95	-0.96	0.62	0.62
Capital Stock	0.95	0.77	-0.71	-0.9	0.88	0.8	-0.39	0.76	-0.66	1.0	0.85	0.91	-0.95		0.91	-0.47	-0.47
Net Working Capital	0.97	0.84	-0.87	-0.86	0.8	0.65	-0.44	0.94	-0.68	0.89	0.78	1.0	-0.96	0.91		-0.48	-0.48
Current Deferred Revenue	-0.36	-0.45	0.27	0.6	-0.77	-0.79	0.23	-0.26	0.42	-0.42	-0.39	-0.52	0.62	-0.47	-0.48		1.0
Intangible Assets	-0.36	-0.45	0.27	0.6	-0.77	-0.79	0.23	-0.26	0.42	-0.42	-0.39	-0.52	0.62	-0.47	-0.48	1.0

Click cells to compare fundamentals

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	910.4 K	955.9 K
Gross Profit Margin	0.36	0.67

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC